The US has authorized the “immediate” resumption of the use of the vaccine by Janssen, the Belgian subsidiary of Johnson & Johnson (J&J), after its administration was practically suspended ten days ago due to cases of thrombosis in women. “We have concluded that the known and potential benefits of the vaccine outweigh its known and potential risks,” said the director of the United States Food and Drug Administration (FDA) at a press conference, adding: “We are sure that this vaccine continues to meet our standards for safety, efficacy, and quality. “
–
Related posts:
Doctors Reveal Causes of Heart Disease at a Young Age, Lazy to Move to Snacking Are the Main Factors
the singer interrupts her concert to announce her health problem to her fans
The Delightful Taste and Health Benefits of Liver Meals: A Comprehensive Guide
This amount of caffeine can cause a heart attack...even if you're healthy
